These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 10448934

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes.
    Henry DJ, Chavkin C.
    Neurosci Lett; 1995 Feb 17; 186(2-3):91-4. PubMed ID: 7777206
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Role of a conserved lysine residue in the peripheral cannabinoid receptor (CB2): evidence for subtype specificity.
    Tao Q, McAllister SD, Andreassi J, Nowell KW, Cabral GA, Hurst DP, Bachtel K, Ekman MC, Reggio PH, Abood ME.
    Mol Pharmacol; 1999 Mar 17; 55(3):605-13. PubMed ID: 10051546
    [Abstract] [Full Text] [Related]

  • 45. Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors.
    Nakazi M, Bauer U, Nickel T, Kathmann M, Schlicker E.
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan 17; 361(1):19-24. PubMed ID: 10651142
    [Abstract] [Full Text] [Related]

  • 46. The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2.
    Darmani NA.
    Eur J Pharmacol; 2001 Oct 26; 430(1):49-58. PubMed ID: 11698062
    [Abstract] [Full Text] [Related]

  • 47. The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors.
    Shoemaker JL, Joseph BK, Ruckle MB, Mayeux PR, Prather PL.
    J Pharmacol Exp Ther; 2005 Aug 26; 314(2):868-75. PubMed ID: 15901805
    [Abstract] [Full Text] [Related]

  • 48. Pharmacological properties of cannabinoid receptors in the avian brain: similarity of rat and chicken cannabinoid1 receptor recognition sites and expression of cannabinoid2 receptor-like immunoreactivity in the embryonic chick brain.
    Fowler CJ, Nilsson O, Andersson M, Disney G, Jacobsson SO, Tiger G.
    Pharmacol Toxicol; 2001 Apr 26; 88(4):213-22. PubMed ID: 11322181
    [Abstract] [Full Text] [Related]

  • 49. Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5'-O-(3-[35S]thio)-triphosphate binding assay in rat cerebellar membranes.
    Griffin G, Atkinson PJ, Showalter VM, Martin BR, Abood ME.
    J Pharmacol Exp Ther; 1998 May 26; 285(2):553-60. PubMed ID: 9580597
    [Abstract] [Full Text] [Related]

  • 50. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.
    Rahn EJ, Makriyannis A, Hohmann AG.
    Br J Pharmacol; 2007 Nov 26; 152(5):765-77. PubMed ID: 17572696
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Novel, not adenylyl cyclase-coupled cannabinoid binding site in cerebellum of mice.
    Monory K, Tzavara ET, Lexime J, Ledent C, Parmentier M, Borsodi A, Hanoune J.
    Biochem Biophys Res Commun; 2002 Mar 22; 292(1):231-5. PubMed ID: 11890697
    [Abstract] [Full Text] [Related]

  • 53. delta 9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain.
    Burkey TH, Quock RM, Consroe P, Roeske WR, Yamamura HI.
    Eur J Pharmacol; 1997 Apr 04; 323(2-3):R3-4. PubMed ID: 9128853
    [Abstract] [Full Text] [Related]

  • 54. AM630 behaves as a protean ligand at the human cannabinoid CB2 receptor.
    Bolognini D, Cascio MG, Parolaro D, Pertwee RG.
    Br J Pharmacol; 2012 Apr 04; 165(8):2561-74. PubMed ID: 21615724
    [Abstract] [Full Text] [Related]

  • 55. Cannabinoid receptor agonist efficacy for stimulating [35S]GTPgammaS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity.
    Breivogel CS, Selley DE, Childers SR.
    J Biol Chem; 1998 Jul 03; 273(27):16865-73. PubMed ID: 9642247
    [Abstract] [Full Text] [Related]

  • 56. Cannabinoid receptor stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding in rat brain membranes.
    Selley DE, Stark S, Sim LJ, Childers SR.
    Life Sci; 1996 Jul 03; 59(8):659-68. PubMed ID: 8761016
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo.
    Pertwee RG, Thomas A, Stevenson LA, Ross RA, Varvel SA, Lichtman AH, Martin BR, Razdan RK.
    Br J Pharmacol; 2007 Mar 03; 150(5):586-94. PubMed ID: 17245367
    [Abstract] [Full Text] [Related]

  • 59. A beneficial aspect of a CB1 cannabinoid receptor antagonist: SR141716A is a potent inhibitor of macrophage infection by the intracellular pathogen Brucella suis.
    Gross A, Terraza A, Marchant J, Bouaboula M, Ouahrani-Bettache S, Liautard JP, Casellas P, Dornand J.
    J Leukoc Biol; 2000 Mar 03; 67(3):335-44. PubMed ID: 10733093
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.